As part of a new study, the EPIC-NSW Research Study, a treatment known as pre-exposure prophylaxis HIV treatment (PrEP) will be available for all people who are HIV negative but at high risk of acquiring HIV. This can include women whose male partners are having sex with men.
PrEP is an antiretroviral medication that is taken by HIV negative people to prevent HIV infection. Studies from around the world have shown that if taken daily, PrEP works.
PrEP is a very effective HIV prevention tool. It is an exciting medical advancement for anyone who might be at high risk of acquiring HIV.
If you think you, or someone you know, may benefit from PrEP, don’t delay – visit Pozhet’s website for more information: http://pozhet.org.au/prep/